TXNIP is considered to be a potential tumor suppressor gene in multiple tumors, including breast cancer [57], hepatocellular carcinoma [58], non-small-cell lung cancer [59], and renal cell carcinoma [60]. The gene discussed is TXNIP; the disease is breast cancer.